← Human Trials & Peer-Reviewed Studies

Vitamin D and Calcium Milk Fortification in Pregnant Women with Periodontitis: A Feasibility Trial.

Plain-language guide to PMID 33143369 (2020): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 69 women.

Key Facts

PMID
33143369
Journal
International journal of environmental research and public health
Year
2020
Study type
Randomized Controlled Trial
Authors
Rodrigues Amorim Adegboye A et al. (10 authors)
DOI
10.3390/ijerph17218023

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

This 2 × 2 factorial feasibility trial used a mixed-methods evaluation.

In total, 69 pregnant women were randomly allocated to four groups: 1. fortified sachet with Ca+VitD and milk plus early PT (throughout gestation); 2. placebo and milk plus early PT; 3. fortified sachet with Ca+VitD and milk plus late PT after childbirth; 4. placebo and milk plus late PT.

Who Took Part

The abstract describes 69 women taking part.

PubMed tags the participants as women only.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

What Was Measured

This 2 × 2 factorial feasibility trial used a mixed-methods evaluation.

Data were collected via questionnaires, field notes, participant flow logs, treatment diary, and focal group discussions.

Topics PubMed links to this paper include Brazil, Calcium Carbonate, Feasibility Studies, Food, Fortified, Milk, Periodontitis and Pregnancy Complications.

The authors tagged it with the keywords acceptability, adherence, attrition rate, milk fortification and periodontal therapy.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 69 women.

The publication is from 2020 (International journal of environmental research and public health), a journal based in Switzerland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.